|
|
3737 Glenwood Avenue, Suite 100 Raleigh, NC 27612 phone:800.781.8926 fax:
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.healthlinkeurope.com
|
|
| Research Sector |
Healthcare Services |
|
 |
| Summary Description |
| Medical Device Distribution Company. |
 |
| Management |
| Rick Hughes, President;
Joost van den Heuvel, CFO;
Paul Smits, COO;
Joachim de Jong, Director of Operations;
Kay Bonavita, Director of Client Relations;
David van de Rustraat, Finance Manager |
| |
|
|
| |
|
| Keywords |
| Third Party Logistics (3PL), Multilingual Customer service call center, Fiscal Rep, Authorized Rep, WEEE Registration, Pick-pack-n-ship, Direct sales support, Car Fleet Management, Invoicing, Accounting, VAT deferment, Reimbursement, Direct sales in Europe, Europe commerlization |
|
|
|
| Description |
|
HealthLink Europe is an ISO 13485 certified Medical Device Distribution Company with facilities in The Netherlands and The United States. HealthLink's mission is to provide our Medical Device customers with the expertise, service and value necessary to accelerate their growth in Europe, while functioning as a transparent extension of their business. |
 |
| Market / Customers |
|
HealthLink is the launch pad for medical device manufacturers that introduce new devices into the European market, providing 3PL fulfillment and back office support services, without costly infrastructure, and promoting flexibility to enable successful exit strategies. Examples of HealthLink customers that have been acquired include EVALVE, ACCLARENT, ATS MEDICAL and ARDIAN . HealthLink's mission is to provide customers with customized expertise and services that will accelerate their business growth in Europe.
An example of three successful emerging companies in both the Cardiology and Orthopedic spaces that currently benefit from HealthLink's European back office services are STENTYS, whose technology consists of a unique, self-expanding stent platform that has been designed and tested to address the challenges of treating coronary arteries, INTRINSIC THERAPEUTICS, dedicated to providing products that enable direct reconstruction of weakened or ruptured anulus and CERAPEDICS that is focused on developing and commercializing novel osteobiologic products.
|
 |
| Strategy |
Our strategy is to allow US Medical device companies to enter into the Europe market without establishing their own infrastructure. By using our knowledgeable staff, financial services and customer services representatives we can have a company up and running in Europe in about 12 weeks. Supporting a direct sales team, shipping directly to hospitals, VAT deferment and answering the phones with multilingual customers service representatives, on the same time zone is the key to a successful Europe launch.
|
 |
|
|
|
|
|
|